Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade
Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat th...
Gespeichert in:
Veröffentlicht in: | Endocrinology (Philadelphia) 2008-05, Vol.149 (5), p.2517-2526 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2526 |
---|---|
container_issue | 5 |
container_start_page | 2517 |
container_title | Endocrinology (Philadelphia) |
container_volume | 149 |
creator | Montaño, Luis M Calixto, Eduardo Figueroa, Alejandra Flores-Soto, Edgar Carbajal, Verónica Perusquía, Mercedes |
description | Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5β-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca2+ inward and K+ outward currents. The fluorescence technique was used to evaluate [Ca2+]i in single myocytes; moreover, simultaneous measurements of [Ca2+]i and vascular contraction were evaluated. 5β-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. l-type Ca2+ currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5β-DHT > 17β-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nm concentrations it was a powerful L-VOCCs antagonist, whereas at μm concentrations it was observed that: 1) its Ca2+ antagonist property is reverted by increasing the l-type inward Ca2+ currents (Ca2+ agonist property); and 2) the [Ca2+]i and cAMP production was increased. The total K+ currents were unaffected by testosterone or 5β-DHT. The data show that 5β-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nm to μm concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca2+]i and cAMP production at high concentrations. |
doi_str_mv | 10.1210/en.2007-1288 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3130588358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2007-1288</oup_id><sourcerecordid>3130588358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-3dd1d3d850c61bf22a99541b86c723896386487770025b104fda738f81cb15203</originalsourceid><addsrcrecordid>eNp1kc1qGzEUhUVooW7aXR9AEEoWjRL9zFia7KZO_yBQMO56kCVNrGRyNZHkUr9WX6PQZ6rMmDaLdCUd-M65Bw5Cbxg9Z5zRCwfnnFJJGFfqCM1YU9VEMkmfoRmlTBDJuXyBXqZ0W2RVVWKGfi3doH_o7APg0OMWbAw3DhIueqkzXm1C1MYb3IaY9SVeuZRDyi4GcHgRwDjIcbJfudGBLRq3NwF8yhctZD198UBWu7E4NH-HFxsN4Abcmuy_-7w7wxosrn__JFd-sysF8uMjyyKiN9lZnMOTOe-HYO60da_Q814Pyb0-vMfo28cPq8Vncv3105dFe02MEDITYS2zwqqamjlb95zrpqkrtlZzI7lQzVyoeaWklJTyes1o1VstheoVM2tWcyqO0cmUO8bwsC31utuwjVBOdoIJWislalWos4kyMaQUXd-N0d_ruOsY7fZzdQ66_Vzdfq6Cvz2E6mT00EcNxqe_Hk55wzhvCnc6cWE7_i-RHBLFRJZVgoke3BhdSv_KPtnjDytutAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130588358</pqid></control><display><type>article</type><title>Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Montaño, Luis M ; Calixto, Eduardo ; Figueroa, Alejandra ; Flores-Soto, Edgar ; Carbajal, Verónica ; Perusquía, Mercedes</creator><creatorcontrib>Montaño, Luis M ; Calixto, Eduardo ; Figueroa, Alejandra ; Flores-Soto, Edgar ; Carbajal, Verónica ; Perusquía, Mercedes</creatorcontrib><description>Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5β-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca2+ inward and K+ outward currents. The fluorescence technique was used to evaluate [Ca2+]i in single myocytes; moreover, simultaneous measurements of [Ca2+]i and vascular contraction were evaluated. 5β-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. l-type Ca2+ currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5β-DHT > 17β-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nm concentrations it was a powerful L-VOCCs antagonist, whereas at μm concentrations it was observed that: 1) its Ca2+ antagonist property is reverted by increasing the l-type inward Ca2+ currents (Ca2+ agonist property); and 2) the [Ca2+]i and cAMP production was increased. The total K+ currents were unaffected by testosterone or 5β-DHT. The data show that 5β-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nm to μm concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca2+]i and cAMP production at high concentrations.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2007-1288</identifier><identifier>CODEN: ENDOAO</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>17β-Estradiol ; Agonists ; Androgens ; Aorta ; Biological and medical sciences ; Calcium (intracellular) ; Calcium antagonists ; Calcium channels ; Calcium channels (L-type) ; Calcium channels (voltage-gated) ; Calcium ions ; Channel gating ; Channels ; Coronary vessels ; Cyclic AMP ; Dihydrotestosterone ; Estrogens ; Fundamental and applied biological sciences. Psychology ; Low concentrations ; Myocytes ; Nifedipine ; Noradrenaline ; Norepinephrine ; Potassium chloride ; Sex hormones ; Testosterone ; Thorax ; Vasodilation ; Vertebrates: endocrinology</subject><ispartof>Endocrinology (Philadelphia), 2008-05, Vol.149 (5), p.2517-2526</ispartof><rights>Copyright © 2008 by the Endocrine Society 2008</rights><rights>2008 INIST-CNRS</rights><rights>Copyright © 2008 by the Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-3dd1d3d850c61bf22a99541b86c723896386487770025b104fda738f81cb15203</citedby><cites>FETCH-LOGICAL-c337t-3dd1d3d850c61bf22a99541b86c723896386487770025b104fda738f81cb15203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20291229$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Montaño, Luis M</creatorcontrib><creatorcontrib>Calixto, Eduardo</creatorcontrib><creatorcontrib>Figueroa, Alejandra</creatorcontrib><creatorcontrib>Flores-Soto, Edgar</creatorcontrib><creatorcontrib>Carbajal, Verónica</creatorcontrib><creatorcontrib>Perusquía, Mercedes</creatorcontrib><title>Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade</title><title>Endocrinology (Philadelphia)</title><description>Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5β-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca2+ inward and K+ outward currents. The fluorescence technique was used to evaluate [Ca2+]i in single myocytes; moreover, simultaneous measurements of [Ca2+]i and vascular contraction were evaluated. 5β-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. l-type Ca2+ currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5β-DHT > 17β-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nm concentrations it was a powerful L-VOCCs antagonist, whereas at μm concentrations it was observed that: 1) its Ca2+ antagonist property is reverted by increasing the l-type inward Ca2+ currents (Ca2+ agonist property); and 2) the [Ca2+]i and cAMP production was increased. The total K+ currents were unaffected by testosterone or 5β-DHT. The data show that 5β-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nm to μm concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca2+]i and cAMP production at high concentrations.</description><subject>17β-Estradiol</subject><subject>Agonists</subject><subject>Androgens</subject><subject>Aorta</subject><subject>Biological and medical sciences</subject><subject>Calcium (intracellular)</subject><subject>Calcium antagonists</subject><subject>Calcium channels</subject><subject>Calcium channels (L-type)</subject><subject>Calcium channels (voltage-gated)</subject><subject>Calcium ions</subject><subject>Channel gating</subject><subject>Channels</subject><subject>Coronary vessels</subject><subject>Cyclic AMP</subject><subject>Dihydrotestosterone</subject><subject>Estrogens</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Low concentrations</subject><subject>Myocytes</subject><subject>Nifedipine</subject><subject>Noradrenaline</subject><subject>Norepinephrine</subject><subject>Potassium chloride</subject><subject>Sex hormones</subject><subject>Testosterone</subject><subject>Thorax</subject><subject>Vasodilation</subject><subject>Vertebrates: endocrinology</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kc1qGzEUhUVooW7aXR9AEEoWjRL9zFia7KZO_yBQMO56kCVNrGRyNZHkUr9WX6PQZ6rMmDaLdCUd-M65Bw5Cbxg9Z5zRCwfnnFJJGFfqCM1YU9VEMkmfoRmlTBDJuXyBXqZ0W2RVVWKGfi3doH_o7APg0OMWbAw3DhIueqkzXm1C1MYb3IaY9SVeuZRDyi4GcHgRwDjIcbJfudGBLRq3NwF8yhctZD198UBWu7E4NH-HFxsN4Abcmuy_-7w7wxosrn__JFd-sysF8uMjyyKiN9lZnMOTOe-HYO60da_Q814Pyb0-vMfo28cPq8Vncv3105dFe02MEDITYS2zwqqamjlb95zrpqkrtlZzI7lQzVyoeaWklJTyes1o1VstheoVM2tWcyqO0cmUO8bwsC31utuwjVBOdoIJWislalWos4kyMaQUXd-N0d_ruOsY7fZzdQ66_Vzdfq6Cvz2E6mT00EcNxqe_Hk55wzhvCnc6cWE7_i-RHBLFRJZVgoke3BhdSv_KPtnjDytutAw</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Montaño, Luis M</creator><creator>Calixto, Eduardo</creator><creator>Figueroa, Alejandra</creator><creator>Flores-Soto, Edgar</creator><creator>Carbajal, Verónica</creator><creator>Perusquía, Mercedes</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>20080501</creationdate><title>Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade</title><author>Montaño, Luis M ; Calixto, Eduardo ; Figueroa, Alejandra ; Flores-Soto, Edgar ; Carbajal, Verónica ; Perusquía, Mercedes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-3dd1d3d850c61bf22a99541b86c723896386487770025b104fda738f81cb15203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>17β-Estradiol</topic><topic>Agonists</topic><topic>Androgens</topic><topic>Aorta</topic><topic>Biological and medical sciences</topic><topic>Calcium (intracellular)</topic><topic>Calcium antagonists</topic><topic>Calcium channels</topic><topic>Calcium channels (L-type)</topic><topic>Calcium channels (voltage-gated)</topic><topic>Calcium ions</topic><topic>Channel gating</topic><topic>Channels</topic><topic>Coronary vessels</topic><topic>Cyclic AMP</topic><topic>Dihydrotestosterone</topic><topic>Estrogens</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Low concentrations</topic><topic>Myocytes</topic><topic>Nifedipine</topic><topic>Noradrenaline</topic><topic>Norepinephrine</topic><topic>Potassium chloride</topic><topic>Sex hormones</topic><topic>Testosterone</topic><topic>Thorax</topic><topic>Vasodilation</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montaño, Luis M</creatorcontrib><creatorcontrib>Calixto, Eduardo</creatorcontrib><creatorcontrib>Figueroa, Alejandra</creatorcontrib><creatorcontrib>Flores-Soto, Edgar</creatorcontrib><creatorcontrib>Carbajal, Verónica</creatorcontrib><creatorcontrib>Perusquía, Mercedes</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montaño, Luis M</au><au>Calixto, Eduardo</au><au>Figueroa, Alejandra</au><au>Flores-Soto, Edgar</au><au>Carbajal, Verónica</au><au>Perusquía, Mercedes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><date>2008-05-01</date><risdate>2008</risdate><volume>149</volume><issue>5</issue><spage>2517</spage><epage>2526</epage><pages>2517-2526</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><coden>ENDOAO</coden><abstract>Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of l-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5β-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca2+ inward and K+ outward currents. The fluorescence technique was used to evaluate [Ca2+]i in single myocytes; moreover, simultaneous measurements of [Ca2+]i and vascular contraction were evaluated. 5β-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. l-type Ca2+ currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5β-DHT > 17β-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nm concentrations it was a powerful L-VOCCs antagonist, whereas at μm concentrations it was observed that: 1) its Ca2+ antagonist property is reverted by increasing the l-type inward Ca2+ currents (Ca2+ agonist property); and 2) the [Ca2+]i and cAMP production was increased. The total K+ currents were unaffected by testosterone or 5β-DHT. The data show that 5β-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nm to μm concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca2+]i and cAMP production at high concentrations.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><doi>10.1210/en.2007-1288</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-7227 |
ispartof | Endocrinology (Philadelphia), 2008-05, Vol.149 (5), p.2517-2526 |
issn | 0013-7227 1945-7170 |
language | eng |
recordid | cdi_proquest_journals_3130588358 |
source | Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | 17β-Estradiol Agonists Androgens Aorta Biological and medical sciences Calcium (intracellular) Calcium antagonists Calcium channels Calcium channels (L-type) Calcium channels (voltage-gated) Calcium ions Channel gating Channels Coronary vessels Cyclic AMP Dihydrotestosterone Estrogens Fundamental and applied biological sciences. Psychology Low concentrations Myocytes Nifedipine Noradrenaline Norepinephrine Potassium chloride Sex hormones Testosterone Thorax Vasodilation Vertebrates: endocrinology |
title | Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist l-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to l-Type Ca2+ Channel Blockade |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A10%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relaxation%20of%20Androgens%20on%20Rat%20Thoracic%20Aorta:%20Testosterone%20Concentration%20Dependent%20Agonist/Antagonist%20l-Type%20Ca2+%20Channel%20Activity,%20and%205%CE%B2-Dihydrotestosterone%20Restricted%20to%20l-Type%20Ca2+%20Channel%20Blockade&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Montan%CC%83o,%20Luis%20M&rft.date=2008-05-01&rft.volume=149&rft.issue=5&rft.spage=2517&rft.epage=2526&rft.pages=2517-2526&rft.issn=0013-7227&rft.eissn=1945-7170&rft.coden=ENDOAO&rft_id=info:doi/10.1210/en.2007-1288&rft_dat=%3Cproquest_cross%3E3130588358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130588358&rft_id=info:pmid/&rft_oup_id=10.1210/en.2007-1288&rfr_iscdi=true |